immune system
• homozygotes display abnormal Th2 development in a pulmonary allergy model
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show an 88% reduction in airway eosinophils relative to wild-type mice
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show an 79% reduction in airway neutrophils relative to wild-type mice
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show an 54% reduction in airway lymphocytes relative to wild-type mice
|
• consistent with a reduction in IL-4-producing cells, Ag-challenged homozygotes show reduced bronchoalveolar lavage levels of Th2 cytokines, IL-5 and IL-13
|
• homozygotes with MOG-induced EAE exhibit an >10-fold increase in IL-1beta mRNA levels; however, no corresponding increase in IL-1beta protein levels (or several other cytokines) is noted in mutant spinal cords
|
• homozygotes exhibit an abrogated adaptive Th2 immune response in an experimental allergic asthma model
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes exhibit reduced eosinophil recruitment into the peribronchial region between pulmonary blood vessels and the airways
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes exhibit reduced lung neutrophil recruitment
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show a 40% reduction in total IgE levels relative to wild-type mice; Ag-specific IgE levels are decreased by 70%
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show a 64% reduction in Ag-specific IgG1 levels relative to wild-type mice
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes display an impaired Th2 immune response, i.e. severely reduced Th2 activation and recruitment to lung
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes display an attenuated allergic (asthma-like) response relative to wild-type mice
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show a 59% reduction in lung IL-4-producing cells relative to wild-type mice
|
• homozygotes exhibit attenuated disease severity in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE), with a lower cumulative disease index relative to wild-type mice (48.2 vs 66.7)
• however, upon in vitro stimulation with MOG35-55 peptide, mutant splenic T cells exhibit normal proliferative (i.e. encephalitogenic-inducing) capacity
|
hematopoietic system
• homozygotes display abnormal Th2 development in a pulmonary allergy model
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show an 88% reduction in airway eosinophils relative to wild-type mice
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show an 79% reduction in airway neutrophils relative to wild-type mice
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show an 54% reduction in airway lymphocytes relative to wild-type mice
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes exhibit reduced eosinophil recruitment into the peribronchial region between pulmonary blood vessels and the airways
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes exhibit reduced lung neutrophil recruitment
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show a 40% reduction in total IgE levels relative to wild-type mice; Ag-specific IgE levels are decreased by 70%
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show a 64% reduction in Ag-specific IgG1 levels relative to wild-type mice
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes display an impaired Th2 immune response, i.e. severely reduced Th2 activation and recruitment to lung
|
respiratory system
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes show a 52% reduction in bronchoalveolar lavage mucin levels relative to wild-type mice
|
• in the A. fumigatus/OVA model of pulmonary allergy, Ag-challenged homozygotes exhibit a significantly attenuated airway responsiveness, as shown by decreased sensitivity to i.v. acetylcholine (ACh) challenge
|
liver/biliary system
• at 14-16 weeks, female homozygotes exhibit impaired liver regeneration, as shown by a reduced number of BrdU-positive hepatocyte nuclei at 48 hrs after CCl4-induced toxic liver injury
|
nervous system
demyelination
(
J:93791
)
• when subjected to MOG-induced EAE, homozygotes exhibit a mild reduction in cellular infiltration and demyelination in the spinal cord relative to wild-type mice
|
homeostasis/metabolism
• consistent with a reduction in IL-4-producing cells, Ag-challenged homozygotes show reduced bronchoalveolar lavage levels of Th2 cytokines, IL-5 and IL-13
|
• homozygotes with MOG-induced EAE exhibit an >10-fold increase in IL-1beta mRNA levels; however, no corresponding increase in IL-1beta protein levels (or several other cytokines) is noted in mutant spinal cords
|